Table 2: Univariate analyses of melatonin association with IL-1B .

Variables	Coefficient	Std. Err	t	P value	95% CI
Sex (Female)	-326	572.87	-0.60	0.50	-1403.73, 751.72
Age	21.47	23.81	0.90	0.37	-25.83, 68.78
BMI	6.50	7.22	0.90	0.30	-7.85, 20.84
Total cholesterol (mg/dL)	1.30	5.64	0.24	0.81	-9.89, 12.55
LDL (mg/dL)	-1.73	9.14	-0.20	0.85	-19.90, 16.48
HDL (mg/dL)	32.03	34.04	0.94	0.35	-35.74, 99.80
Triglyceride (mg/dL)	2.48	3.32	0.75	0.45	-4.12, 9.10
AST (U/L)	24.59	8.20	3.00	0.003	8.31, 40.86
ALT (U/L)	21.52	6.03	3.54	0.001	9.45, 33.59
Alkaline phosphatase (U/L)	5.32	4.28	1.24	0.20	-3.17, 13.83
FBS	16.42	8.90	1.85	0.060	-1.30, 34.17
Stages of fibrosis
Mild to moderate	374	617.10	0.61	0.05	-851.28, 1599.28
Severe	1683.17	623.90	2.70	0.006	444.35, 2921.99
Stages of steatosis
Mild to moderate	-20.58	721.72	-0.03	0.977	-1453.59, 1412.43
Severe	1472.96	594.78	2.48	0.015	292.01, 2653.91
Melatonin	3.45	0.40	8.53	< 0.001	2.64, 4.25

BMI: body mass index; AST: Aspartate transaminase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; FBS: Fasting blood sugar